TABLE 1.

Demographics of vaccinated subjects in this studya

CharacteristicTrL3-4aTrL3-8aTrL-8nL7-8aL7-8nVAMen
Total no. vaccinated252525252525
Mean age, yr (SD)21.6 (2.3)22.5 (2.0)21.8 (2.3)21.1 (2.6)22.2 (2.5)21.9 (2.2)
Female-to-male ratio19:612:137:1815:1011:1413:12
  • a TrL3-4a, TrL3 with 4 μg LOS, adsorbed formulation; TrL3-8a, TrL3 with 8 μg LOS, adsorbed formulation; TrL3-8n, TrL3 with 8 μg LOS, nonadsorbed formulation; L7-8a, L7 with 8 μg LOS, adsorbed formulation; L7-8n, L7 with 8 μg LOS, nonadsorbed formulation; VAMen, licensed VA-Mengoc-BC (control group).